FDA NDC Directory · JSON-LD · Markdown

VYVGART Hytrulo

NDC 73475-3102 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameefgartigimod alfa and hyaluronidase (human recombinant)
Labeler / Manufacturerargenx US
Marketing categoryBiologic License Application · App BLA761304
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsEFGARTIGIMOD ALFA (180 mg/mL)
HYALURONIDASE (HUMAN RECOMBINANT) (2000 U/mL)
Marketing started20230620
Package count1

External sources

Source: openFDA. Public-domain (CC0).